banner
sibucz.bsky.social
Simon Buczacki
@sibucz.bsky.social
220 followers 260 following 7 posts
Richard Blackwell Pharsalia Professor of Colorectal Surgery | Group Leader, NDS (ORCRB) | Fellow of Linacre | University of Oxford
Posts Media Videos Starter Packs
sibucz.bsky.social
Simon Buczacki @sibucz.bsky.social · 3d
New CRUK Post-doc position in our group. #mutationalorder #multiomics #cancer.
my.corehr.com/pls/uoxrecru...
Job Details
my.corehr.com
6 2
sibucz.bsky.social
Simon Buczacki @sibucz.bsky.social · Sep 3
t.co/wF4ql4c3V8

We're humbled to have been awarded a CRUK Programme Foundation Award to further progress our work on mutational order in cancer. New post-doctoral positions in our group to be advertised shortly. @ndsurgicalsci.bsky.social @oxfordcancer.bsky.social
https://www.linkedin.com/posts/cancer-research-uk-science-and-innovation_crukfunded-discoveryresearch-cancerresearch-activity-7368945889794633728-3yLM?utm_source=share&utm_medium=member_desktop&rcm=AC...
t.co
1 2 4
sibucz.bsky.social
Simon Buczacki @sibucz.bsky.social · Jul 25
Fantastic end to a good week for the lab. Amazing grant news. Paper submitted. Gold LEAF accreditation.
5
sibucz.bsky.social
Simon Buczacki @sibucz.bsky.social · Feb 14
Broad implications for path/surgical standards and CME
1
sibucz.bsky.social
Simon Buczacki @sibucz.bsky.social · Feb 14
Each additional node however provides a survival benefit - an effect driven by tumour biology. Lymph node yield = prognostic marker rather than quality indicator.
1 1
sibucz.bsky.social
Simon Buczacki @sibucz.bsky.social · Feb 14
New paper. Why do we try to remove increasingly large numbers of lymph nodes in colon cancer surgery? Here we follow up our BJC 2022 paper with ~370K patients in England and USA. Only 9 LNs are required to stage the cancer.
www.nature.com/articles/s41...
Lymph node yield as a surrogate marker for tumour biology and prognosis in colon cancer - British Journal of Cancer
British Journal of Cancer - Lymph node yield as a surrogate marker for tumour biology and prognosis in colon cancer
www.nature.com
1 1 5
sibucz.bsky.social
Simon Buczacki @sibucz.bsky.social · Jan 27
www.cancer.ox.ac.uk/news/oxford-...
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent ...
www.cancer.ox.ac.uk
5 16